+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Gastroparesis Market and Competitive Landscape - 2020

  • ID: 5023407
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Gastroparesis Market and Competitive Landscape - 2020, provides comprehensive insights into the Gastroparesis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Gastroparesis market size and drug sales. It also provides insights into Gastroparesis epidemiology and late stage pipeline.

This research covers the following: Gastroparesis treatment options, Gastroparesis late stage clinical trials pipeline, Gastroparesis prevalence by countries, Gastroparesis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Gastroparesis pipeline: Find out drugs in clinical trials for the treatment of Gastroparesis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Gastroparesis epidemiology: Find out the number of patients diagnosed (prevalence) with Gastroparesis by countries
  • Gastroparesis drugs: Identify key drugs marketed and prescribed for Gastroparesis in the US, including trade name, molecule name, and company
  • Gastroparesis drugs sales: Find out the sales value for Gastroparesis drugs by countries
  • Gastroparesis market valuations: Find out the market size for Gastroparesis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Gastroparesis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Gastroparesis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Gastroparesis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Gastroparesis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Gastroparesis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Gastroparesis Treatment Options

2. Gastroparesis Pipeline Insights
2.1. Gastroparesis Phase 3 Clinical Trials
2.2. Gastroparesis Phase 2 Clinical Trials
2.3. Gastroparesis Phase 1 Clinical Trials

3. Gastroparesis Epidemiology Analysis by Countries

4. Germany Gastroparesis Market Insights
4.1. Marketed Drugs for Gastroparesis in Germany
4.2. Germany Gastroparesis Market Size & Forecast
4.3. Germany Gastroparesis Drugs Sales Forecast
4.4. Germany Gastroparesis Market Share Analysis

5. France Gastroparesis Market Insights
5.1. Marketed Drugs for Gastroparesis in France
5.2. France Gastroparesis Market Size & Forecast
5.3. France Gastroparesis Product Sales Forecast
5.4. France Gastroparesis Market Share Analysis

6. Italy Gastroparesis Market Insights
6.1. Marketed Drugs for Gastroparesis in Italy
6.2. Italy Gastroparesis Market Size & Forecast
6.3. Italy Gastroparesis Product Sales Forecast
6.4. Italy Gastroparesis Market Share Analysis

7. Spain Gastroparesis Market Insights
7.1. Marketed Drugs for Gastroparesis in Spain
7.2. Spain Gastroparesis Market Size & Forecast
7.3. Spain Gastroparesis Product Sales Forecast
7.4. Spain Gastroparesis Market Share Analysis

8. UK Gastroparesis Market Insights
8.1. Marketed Drugs for Gastroparesis in UK
8.2. UK Gastroparesis Market Size & Forecast
8.3. UK Gastroparesis Product Sales Forecast
8.4. UK Gastroparesis Market Share Analysis

9. Europe Gastroparesis Market Insights
9.1. Europe Gastroparesis Market Size & Forecast
9.2. Europe Gastroparesis Product Sales Forecast
9.3. Europe Gastroparesis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Gastroparesis Phase 3 Clinical Trials, Global, 2020
Table 2: Gastroparesis Phase 2 Clinical Trials, Global, 2020
Table 3: Gastroparesis Phase 1 Clinical Trials, Global, 2020
Table 4: Gastroparesis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Gastroparesis in Germany, 2019
Table 6: Germany Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Gastroparesis Product Sales ($mn), 2016 - 2024
Table 8: Germany Gastroparesis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Gastroparesis in France, 2019
Table 10: France Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Gastroparesis Product Sales ($mn), 2016 - 2024
Table 12: France Gastroparesis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Gastroparesis in Italy, 2019
Table 14: Italy Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Gastroparesis Product Sales ($mn), 2016 - 2024
Table 16: Italy Gastroparesis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Gastroparesis in Spain, 2019
Table 18: Spain Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Gastroparesis Product Sales ($mn), 2016 - 2024
Table 20: Spain Gastroparesis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Gastroparesis in UK, 2019
Table 22: UK Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Gastroparesis Product Sales ($mn), 2016 - 2024
Table 24: UK Gastroparesis Market Events and Trends, 2016 - 2024
Table 25: Europe Gastroparesis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Gastroparesis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Gastroparesis Pipeline by Phase (%), Global, 2020
Figure 2: Gastroparesis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Gastroparesis Market Size ($mn), 2016 - 2024
Figure 4: Germany Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Gastroparesis Market Share by Drugs (%), 2019
Figure 6: Germany Gastroparesis Market - Future Market Share (%), 2024
Figure 7: France Gastroparesis Market Size ($mn), 2016 - 2024
Figure 8: France Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 9: France Gastroparesis Market Share by Drugs (%), 2019
Figure 10: France Gastroparesis Market - Future Market Share (%), 2024
Figure 11: Italy Gastroparesis Market Size ($mn), 2016 - 2024
Figure 12: Italy Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Gastroparesis Market Share by Drugs (%), 2019
Figure 14: Italy Gastroparesis Market - Future Market Share (%), 2024
Figure 15: Spain Gastroparesis Market Size ($mn), 2016 - 2024
Figure 16: Spain Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Gastroparesis Market Share by Drugs (%), 2019
Figure 18: Spain Gastroparesis Market - Future Market Share (%), 2024
Figure 19: UK Gastroparesis Market Size ($mn), 2016 - 2024
Figure 20: UK Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 21: UK Gastroparesis Market Share by Drugs (%), 2019
Figure 22: UK Gastroparesis Market - Future Market Share (%), 2024
Figure 23: Europe Gastroparesis Market Size ($mn), 2016 - 2024
Figure 24: Europe Gastroparesis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Gastroparesis Market Share by Drugs (%), 2019
Figure 26: Europe Gastroparesis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll